homephotos Newsmarket Newsstocks News

Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23

Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23

Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23
Profile image

By CNBCTV18.com Mar 23, 2022 4:02:59 PM IST (Updated)

Switch to Slide Show
Slide Show


Benchmark indices ended lower with Nifty below 17,300 in the volatile session on Wednesday. At close, the Sensex was down 0.53 percent at 57,684.82, and the Nifty was down 0.40 percent at 17,245.70. Here are the key stocks that moved the most in trade today:

paytm, paytm ipo, paytm ipo grey market price
Image count1 / 5

Paytm | Share price of One 97 Communications, the parent firm of Paytm, rose over 3 percent in the early trade today after the company clarified on the BSE query. The BSE on March 22 sought clarification from One 97 Communications, over the sharp fall in its share prices. The shares, however, ended 4 percent lower.

Image count2 / 5

Bajaj Electricals | Bajaj Electricals share price edged higher by over 2 percent intraday on Wednesday after the company renewed trade licensing agreement with Morphy Richards for 15 years. The shares closed at 1.31 percent higher.

Image count3 / 5

Hero MotoCorp | Hero MotoCorp share price slipped 4 percent intraday today after the Income Tax (I-T) department conducted search operations at the company's 25 premises. The department is conducting the search operations at the offices and residences of Hero MotoCorp senior management in Delhi, Gururgram and in other parts of North India. The shares of the company ended 1.37 percent lower.

Indian Hotels Puneet Chhatwal
Image count4 / 5

Indian Hotels | A meeting of the QIP Committee of the board of directors of Indian Hotels Company is scheduled to be held on March 25 to consider and approve the issue price, including a discount, if any, for the equity shares to be allotted to qualified institutional buyers. The shares ended 3.50 percent higher.

Image count5 / 5

Gland Pharma | Jefferies kept a 'buy' rating on Gland Pharma with a target at Rs 4,578 per share. Jefferies hosted Gland Pharma for a UK/EU roadshow recently. The management guided growth visibility in all key markets. The company expects 20-25 percent revenue CAGR in the medium term, while margin is expected to be steady with volume growth countering gross margin dilution. Shares of the company ended 2.35 percent higher.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
arrow down

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers